Evaluation of an Anti-HIV Drug Combination That Includes a Coated Form of Didanosine (ddI EC) Compared to a Typical Anti-HIV Drug Regimen

• Status: Completed
• Trial end date: 2001-01-01

Summary

This study tests a new form of didanosine, ddI EC, a coated pill that passes through the stomach before dissolving. The purpose of this study is to compare the effectiveness of an anti-HIV drug combination that includes ddI EC versus another anti-HIV drug combination.

• Phase: Phase 3

Details

• Lead Sponsor: Bristol-Myers Squibb
• Treatments: Didanosine; Lamivudine; Lamivudine, zidovudine drug combination; Nelfinavir; Stavudine; Zidovudine